Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 17/20 | 0.80 |
| ▸ | CNR1 | P21554 | 9/20 | 0.80 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13502770 | 0.99 | CNR2 (0.81) | CNR2CNR1HDAC1HDAC6 | |
| SCHEMBL17297543 | 0.90 | CNR2 (0.80) | CNR2CNR1HDAC1HDAC6 | |
| SCHEMBL31052991 | 0.89 | CNR2 (0.81) | CNR2CNR1HDAC1HDAC6 | |
| SCHEMBL29359055 | 0.89 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL13502771 | 0.89 | CNR2 (0.81) | CNR2CNR1HDAC1HDAC6 | |
| SCHEMBL24222016 | 0.89 | CNR2 (0.81) | CNR2CNR1HDAC1HDAC6 | |
| SCHEMBL16755272 | 0.89 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL17388191 | 0.89 | CNR2 (0.81) | CNR2CNR1HDAC1HDAC6 | |
| SCHEMBL17388587 | 0.88 | CNR2 (0.79) | CNR2CNR1HDAC1HDAC6 | |
| SCHEMBL13502769 | 0.86 | CNR2 (0.77) | CNR2CNR1HDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270763-A1 | METHOD OF TREATING CORONOVIRUS INFECTIONS WITH CANNABINOIDS AND DERIVATIVES | PASCAL BIOSCIENCES INC (CA) | 2023-08-31 | — | — | US | disclosed |
| CN-116297923-A | Rapid identification method for indole and indazole type synthetic cannabinoid novel psychoactive substance structure | 广西大学 | 2023-06-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270763-A1 | METHOD OF TREATING CORONOVIRUS INFECTIONS WITH CANNABINOIDS AND DERIVATIVES | CNR1, CNR2, SARS1 | CNR2 2/4885CNR1 1/4885HDAC1 3712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.